The modern combination protocols have replaced it, which is why our Doral clinic prescribes CJC-1295/Ipamorelin and Tesamorelin and does not offer Sermorelin
Weeks 12: 2 mg once weekly Weeks 36: 4 mg once weekly Weeks 710: 8 mg once weekly Week 11+: 12 mg once weekly (if tolerated) Fast escalation: Select cases, monitored closely This fast-escalation schedule is used only in specific situations where close supervision is available, such as in specialty clinics or structured clinical trial settings that follow strict safety protocols
10.1016/j.cell.2013.05.002 102 SteinerB.KlempinF.WangL.KottM.KettenmannH.KempermannG
Nausea/aversion The concern with nausea resulting from GLP-1 should not come as a surprise as this is in fact the most common side effect reported in patients receiving GLP-1 analog treatment (Calara et al., 1997, 1998
The most common ones were: More predictable periods: 45% of all respondents and 64% of those with PCOS More frequent periods: 21% of all respondents and 23% of those with PCOS Shorter periods: 19% of all respondents and 20% of those with PCOS When looking at these results, its worth noting that other factors can impact the menstrual cycle too, and its difficult to separate which cycle changes are specifically due to the GLP-1 medications